Antifungal prophylaxis in lung transplantation

Area of Science:

• Medicine
• Infectious Diseases
• Transplantation

Background:

• Lung transplant recipients are highly susceptible to invasive fungal infections (IFIs), especially invasive aspergillosis.
• Current diagnostic tools for IFIs in these patients have limited sensitivity and specificity, delaying appropriate antifungal therapy.
• High mortality rates and treatment costs associated with IFIs underscore the importance of effective antifungal prophylaxis.

Purpose of the Study:

• To review the epidemiology, risk factors, and clinical features of fungal infections post-lung transplant.
• To critically evaluate the efficacy, safety, and practicality of existing antifungal prophylactic strategies in lung transplant recipients.
• To identify challenges and research gaps in antifungal prophylaxis for lung transplant patients.

Main Methods:

• Literature review of studies on fungal infections and antifungal prophylaxis in lung transplant recipients.
• Analysis of evidence regarding diagnostic challenges and treatment outcomes.
• Synthesis of current prophylactic approaches and future research directions.

Main Results:

• Invasive fungal infections pose a significant threat to lung transplant recipients.
• Optimal antifungal prophylaxis strategies lack consistent evidence, presenting a clinical challenge.
• Existing diagnostic methods are insufficient for timely pathogen identification.

Conclusions:

• Antifungal prophylaxis is crucial for lung transplant recipients due to high IFI risk and mortality.
• Further research is needed to establish evidence-based, optimal prophylactic regimens.
• Improved diagnostics and tailored prophylaxis are essential for better patient outcomes.